SOPHIA BROWNSTEIN: Open Payments
NPI 1174235360 · CRANSTON, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$413 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $97 · 2025 $413
Food & beverage: $413
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 2 | $165 |
| Sage Therapeutics, LLC | 3 | $57 |
| Sumitomo Pharma America, Inc. | 2 | $48 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| SHIELD THERAPEUTICS INC | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| PFIZER INC. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: NEXPLANON, ZURZUVAE, MYFEMBREE, GARDASIL 9, ACCRUFER, Lynkuet, TRUMENBA, Qelbree.
Industry payments across RI — which companies pay providers there.
